Bloom Energy is under pressure this week, down 10% Tuesday to $209 — and the most striking feature of the current setup isn't the short book, it's the wave of insider selling that landed as the stock was trading near its highest levels of the year.
The insider activity is hard to dismiss as noise. Director Jeff Immelt sold 30,000 shares on August 17 for roughly $7.2 million. Fellow director John Chambers sold 15,000 shares on August 13 at $250, following an identical 15,000-share sale on August 3 at $205. The CCO, COO, and CLO all trimmed on August 14. Net insider activity over 90 days shows net selling of around $38.5 million in value, even though the share count nets slightly positive — a gap explained by higher prices achieved on the sells. The cluster of C-suite and board-level disposals across a two-week window, with the stock between $205 and $251, looks like deliberate distribution near perceived fair value, not routine diversification.
Short positioning continues the rebuilding trend flagged in last week's note, and it has extended further. Short interest now stands at 8.7% of the free float — up another 9% on the week and 12% over the past month. The jump from roughly 18.7 million shares short in late July to over 20.5 million today is a meaningful re-accumulation. The borrow market remains no obstacle: cost to borrow is just 0.34%, and availability is extraordinarily loose at nearly 3,800% of short interest, meaning the lending pool is nowhere near stressed. Bears can add to positions cheaply. The ORTEX short score has crept higher to 40.1, up from 38.6 two weeks ago — not yet at elevated levels, but the direction is consistent.
Options positioning has eased from the more defensive stance seen in late July. The put/call ratio is now at 1.05 — below its 20-day average of 1.11 and almost a full standard deviation below that mean. That's actually a mild shift toward calls relative to recent norms, which sits in some tension with the price weakness. The 52-week PCR range of 0.59 to 1.43 puts the current reading roughly in the middle, suggesting the options market isn't yet pricing a directional conviction bet in either direction.
The Street's reaction to last month's earnings was telling. The stock dropped 13% the day after the July 28 print, though it recovered to a 21% gain over the following five days — a pattern that reflects how violently sentiment can swing in a name with this much embedded momentum. Analysts largely cut targets post-earnings: JP Morgan trimmed to $314 from $346, UBS moved to $300 from $350, and several neutral-rated firms lowered their numbers into the $218–$229 range. Jefferies, in the most recent action on August 14, raised its Hold-rated target to $229 from $188 — a acknowledgment of the stock's move but no signal of conviction. The consensus mean target now sits around $275, implying roughly 32% upside from current levels. Against a PE of 56x and EV/EBITDA near 47x, bulls rest their case on EPS momentum that ranks in the 96th–97th percentile and the data-center demand story with Oracle and AEP as anchor customers. Bears point to hydrogen niche risk, execution dependency, and a valuation that leaves little room for disappointment.
The institutional picture adds one more layer. Jane Street reported a position of nearly 10 million shares added to reach 14.9 million — a significant build, though Jane Street's holdings frequently reflect options market-making inventory rather than directional conviction. JP Morgan Asset Management added 4.7 million shares in the same reporting period. The next earnings event is scheduled for October 29, and with insider selling clustering at these levels and shorts rebuilding steadily, the weeks leading into that print will test whether the data-center demand thesis can hold the stock above the $200 level that has now become the immediate focus.
See the live data behind this article on ORTEX.
Open BE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
